105 related articles for article (PubMed ID: 10028479)
1. Importance of IgG4 determination in in vitro immunotherapy follow-up of inhalant allergens.
Oehling AK; Sanz ML; Resano A
J Investig Allergol Clin Immunol; 1998; 8(6):333-9. PubMed ID: 10028479
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
3. Reliability of histamine release test in dust mite allergy: influence of the degree of sensitization.
Resano A; Prieto I; Sanz ML; Oehling A
J Investig Allergol Clin Immunol; 1995; 5(5):289-93. PubMed ID: 8574438
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
5. [The histamine liberation test as a diagnostic parameter and its possible modification following specific immunotherapy].
Engel P; Malet A; Sanosa J; Fajas L; García-Calderón PA
Allergol Immunopathol (Madr); 1985; 13(2):93-100. PubMed ID: 2408457
[TBL] [Abstract][Full Text] [Related]
6. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
[TBL] [Abstract][Full Text] [Related]
7. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
9. IgE antibodies to aeroallergens in allergic children in São Paulo, Brazil.
Rizzo MC; Fernández-Caldas E; Solé D; Naspitz CK
J Investig Allergol Clin Immunol; 1997; 7(4):242-8. PubMed ID: 9330189
[TBL] [Abstract][Full Text] [Related]
10. Cluster versus conventional immunotherapy in patients allergic to Dermatophagoides pteronyssinus: a controlled study of in vivo and in vitro parameters.
Muro MD; Tabar AI; Lizaso MT; Quirce S; Polo F; García BE
J Investig Allergol Clin Immunol; 1999; 9(3):146-54. PubMed ID: 10412676
[TBL] [Abstract][Full Text] [Related]
11. Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus.
García BE; Sanz ML; Wong E; Oehling A
Allergol Immunopathol (Madr); 1988; 16(6):379-83. PubMed ID: 3242375
[TBL] [Abstract][Full Text] [Related]
12. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
Delaunois L; Salamon E; Prignot J
Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
[TBL] [Abstract][Full Text] [Related]
13. Specific immunotherapy 3 years follow-up in asthmatic children.
Ferreira N; Trindade JC
Allergol Immunopathol (Madr); 1993; 21(5):185-92. PubMed ID: 8160563
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehyde-modified extract against an unmodified extract: a comparative study of efficacy, tolerance and in vivo and in vitro modification of parameters.
Echechipía S; Tabar AI; Lobera T; Muñoz D; Rodríguez A; Blasco A; Olaguíbel JM; Casanovas M; Fernández de Corres L
J Investig Allergol Clin Immunol; 1995; 5(6):325-32. PubMed ID: 8653220
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to Alternaria and Cladosporium in asthmatic patients and its in vitro diagnostic confirmation.
Resano A; Sanz ML; Oehling A
J Investig Allergol Clin Immunol; 1998; 8(6):353-8. PubMed ID: 10028482
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
17. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
18. [Interest of allergology evaluation for the treatment of asthma and rhinosinusitis].
Michel O
Rev Med Brux; 2008 Sep; 29(4):393-9. PubMed ID: 18949994
[TBL] [Abstract][Full Text] [Related]
19. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
